HECTD3 and cancer: HECTD3 ubiquitinates p62 at K420 via K63 and K29 linked polyubiquitin chains and promotes autophagy and DSB repair, and its genetic ablation or pharmacological inhibition has shown to be a promising strategy to increase radiosensitivity of cancer cells.